Salmonella infection vaccine (siderophore-based) (University of California Irvine)

N/A

Report date: 2025/01/26 16:53:54

Base Information

Drug NameSalmonella infection vaccine (siderophore-based) (University of California Irvine)
Drug Alias Namesiderophore vaccine (University of California Irvine)E coli-associated inflammatory bowel disease vaccine (siderophore-based) (University of California Irvine)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInflammatory Bowel DiseasesSalmonella InfectionsEscherichia coli Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California IrvineUniversity Of California
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesSalmonella InfectionsEscherichia coli Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A